V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008952 | 220003620 | 1.84 | null | Curative (C) | 2016-05-21 | 2016-05-25 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | null | null | 220035580 | CYTARABINE IT + METHOTREXATE |
| 220008953 | 220019033 | null | 86 | null | 2017-05-24 | 2017-05-25 | Fludarabine + Melphalan RIC Allo | N | null | 220035585 | DACARBAZINE |
| 220008954 | 220003621 | 1.47 | 52.65 | Palliative (P) | 2017-05-31 | 2017-08-02 | DOXORUBICIN | 02 | N | 220035588 | DOXORUBICIN |
| 220008955 | 220003622 | null | 50.9 | Curative (C) | 2016-05-31 | 2016-05-31 | MITOXANTRONE + TRETINOIN | N | N | 220035589 | TRIPLE INTRATHECAL |
| 220008956 | 220011969 | 1.77 | 89 | Palliative (P) | 2014-05-24 | 2014-05-30 | Capecitabine + Cisplatin | N | N | 220035590 | VEMURAFENIB |
| 220008957 | 220003623 | 0 | 63.15 | Disease modification (D) | 2014-08-17 | 2014-08-17 | UKALL14- Ph 1 Induction | N | N | 220035592 | MITOXANTRONE |
| 220008958 | 220011970 | 1.68 | 60.3 | Disease modification (D) | 2013-05-20 | 2015-09-04 | CISPLATIN + ETOPOSIDE | N | N | 220035593 | CABOZANTINIB |
| 220008959 | 220011970 | 1.78 | 131.2 | Disease modification (D) | 2017-11-02 | 2017-11-22 | FLUOROURACIL | N | N | 220035593 | ARSENIC TRIOXIDE + TRETINOIN |
| 220008960 | 220011970 | 0 | 95 | Neo-adjuvant (N) | 2017-08-21 | 2017-08-21 | Ipilimumab | 02 | null | 220035593 | RUXOLITINIB |
| 220008961 | 220011970 | null | 106.3 | Curative (C) | 2015-05-15 | 2015-05-15 | Dacarbazine | 3 | Y | 220035593 | MITOXANTRONE |
| 220008962 | 220003624 | 1.64 | 52.5 | Palliative (P) | 2014-11-08 | 2014-11-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | 220035603 | IRINOTECAN + MDG |
| 220008963 | 220003625 | 1.72 | 73.3 | Palliative (P) | null | 2014-03-19 | BOSUTINIB | null | null | 220035607 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 220008964 | 220003626 | 1.69 | null | Palliative (P) | 2014-07-17 | 2014-07-17 | Cisplatin + Etoposide po&iv 3 day | 2 | N | 220035608 | CAPECITABINE |
| 220008965 | 220011971 | null | 78.4 | Curative (C) | 2013-07-25 | 2013-07-25 | PEG INTERFERON | N | N | 220035609 | UKALL2011 |
| 220008966 | 220011971 | null | null | Palliative (P) | null | 2014-08-01 | CHOP R - 21 days | null | null | 220035609 | TEMOZOLOMIDE |
| 220008967 | 220011971 | 1.53 | 54.1 | Palliative (P) | 2015-05-29 | 2015-06-01 | Capecitabine + Streptozocin | N | N | 220035609 | FCIST |
| 220008968 | 220011971 | 1.03 | 57 | Palliative (P) | 2014-07-07 | 2014-07-15 | Triple / Double Intrathecal Therapy | N | N | 220035609 | DOCETAXEL |
| 220008969 | 220011971 | 0 | 85 | Palliative (P) | 2014-03-26 | 2014-03-28 | Cyclophosphamide High Dose | 01 | N | 220035609 | LI-1 TRIAL |
| 220008970 | 220021781 | 1.48 | 86.2 | Palliative (P) | 2016-04-19 | 2016-05-20 | Methotrexate Intrathecal (any age) | 02 | Y | 220035622 | CISPLATIN + ETOPOSIDE |
| 220008971 | 220003627 | 1.87 | 59.2 | Palliative (P) | null | 2014-06-06 | IDARUBICIN | null | Y | 220035625 | CISPLATIN + ETOPOSIDE |
| 220008972 | 220003628 | 1.57 | 67 | Curative (C) | 2014-09-02 | 2014-09-05 | BOSUTINIB | 2 | null | 220035628 | ATG + BUSULFAN + FLUDARABINE |
| 220008973 | 220003629 | 1.8 | 0 | Disease modification (D) | 2015-06-20 | 2015-06-21 | CISPLATIN + ETOPOSIDE | 2 | N | 220035630 | PONATINIB |
| 220008974 | 220003630 | 1.64 | 82 | Palliative (P) | 2014-08-09 | 2014-08-09 | ATG + Busulfan + Fludarabine | N | N | 220035632 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220008975 | 220003630 | 1.74 | 94 | Palliative (P) | 2017-11-18 | 2017-11-19 | CHOP - 21 days | 02 | N | 220035632 | IPILIMUMAB |
| 220008976 | 220003630 | 1.8 | 0 | Palliative (P) | 2014-10-03 | 2014-10-23 | CVP R | N | N | 220035632 | LI-1 TRIAL |
| 220008977 | 220003630 | 1.58 | 67 | Palliative (P) | null | 2016-12-16 | FEC | N | N | 220035632 | IRINOTECAN + MDG |
| 220008978 | 220003630 | 0.01 | 90 | Palliative (P) | 2016-06-11 | 2016-06-17 | Dacarbazine | N | Y | 220035632 | DOCETAXEL |
| 220008979 | 220003631 | null | null | Palliative (P) | 2017-01-29 | 2017-01-29 | Fludarabine + Melphalan RIC Allo | N | null | 220035641 | CTD |
| 220008980 | 220003631 | 1.8 | 67.2 | Disease modification (D) | null | 2016-09-06 | Capecitabine | null | null | 220035641 | BENDAMUSTINE + RITUXIMAB |
| 220008981 | 220016462 | 1.81 | null | Curative (C) | 2013-04-04 | 2013-04-06 | Cetuximab 7 day (>Cycle 2) | N | N | 220035643 | UKALL2014 |
| 220008985 | 220003633 | null | 51 | Palliative (P) | 2014-07-28 | 2014-07-28 | LENALIDOMIDE | N | N | 220035649 | CISPLATIN + FLUORO + STREPTOZOCIN |
| 220008986 | 220003634 | null | null | Neo-adjuvant (N) | null | 2017-03-12 | IMATINIB + HYDROXYCARBAMIDE | null | null | 220035650 | FCR |
| 220008989 | 220003636 | 1.73 | 91 | Palliative (P) | 2015-04-25 | 2015-04-26 | Carboplatin + Pemetrexed | 02 | N | 220035655 | DABRAFENIB + TRAMETINIB |
| 220008990 | 220003636 | 1.85 | 111 | Neo-adjuvant (N) | 2015-11-10 | 2015-11-10 | CHOP R - 21 days | N | N | 220035655 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220008991 | 220003637 | 1.78 | 0 | Disease modification (D) | 2017-10-12 | 2017-10-20 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | 220035658 | IDARUBICIN |
| 220008992 | 220003637 | null | null | null | 2015-07-14 | 2015-07-19 | Triple / Double Intrathecal Therapy | N | N | 220035658 | FLUOROURACIL + MITOMYCIN + RT |
| 220008993 | 220003637 | 1.57 | null | null | null | 2018-07-22 | UKALL14- Ph 1 Induction | null | N | 220035658 | ALEMTUZUMAB |
| 220008994 | 220003637 | 1.65 | 60.5 | Palliative (P) | 2015-04-24 | 2015-05-15 | CHOP R - 21 days | N | N | 220035658 | DABRAFENIB + TRAMETINIB |
| 220008995 | 220003637 | 1.7 | 73.4 | Palliative (P) | 2016-09-24 | 2016-10-01 | Bortezomib +/- Dexamethasone | 02 | N | 220035658 | RUXOLITINIB |
| 220008996 | 220021329 | null | 82 | Palliative (P) | 2017-04-11 | 2017-04-11 | Vincristine (weekly) | N | N | 220035664 | LI-1 TRIAL |
| 220008997 | 220021329 | null | 80 | Palliative (P) | 2013-05-22 | 2013-05-28 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | N | N | 220035664 | VINCRISTINE |
| 220008998 | 220003638 | 1.78 | 102 | Palliative (P) | 2014-04-03 | 2014-05-02 | LENALIDOMIDE | N | N | 220035667 | IPILIMUMAB + NIVOLUMAB |
| 220008999 | 220003639 | null | 78.2 | Palliative (P) | 2013-07-02 | 2013-07-16 | Cisplatin | N | N | 220035668 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 220009000 | 220003640 | 1.8 | 0 | Palliative (P) | 2013-09-04 | 2013-09-10 | CARBO + FLUOROURACIL | N | N | 220035669 | CISPLATIN + ETOPOSIDE |
| 220009001 | 220003641 | 1.77 | 104.9 | Palliative (P) | 2015-05-13 | 2015-05-13 | R GCVP | 2 | N | 220035672 | RUXOLITINIB |
| 220009002 | 220003641 | 1.61 | null | null | 2014-03-29 | 2014-04-05 | LENALIDOMIDE | null | null | 220035672 | METHOTREXATE HIGH DOSE |
| 220009003 | 220003641 | 1.49 | 78.6 | Palliative (P) | 2016-11-17 | 2016-12-02 | Capecitabine | N | N | 220035672 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 220009004 | 220003641 | 1.66 | 93 | Palliative (P) | 2013-07-26 | 2013-08-01 | Fludarabine + Melphalan RIC Allo | 2 | N | 220035672 | ECARBOX |
| 220009005 | 220003641 | 1.8 | null | Palliative (P) | null | 2017-11-30 | Cisplatin + Pemetrexed | N | N | 220035672 | DACARBAZINE |
| 220009006 | 220003641 | 1.72 | 0 | Palliative (P) | 2015-04-22 | 2015-04-22 | Capecitabine (14 day) + Irinotecan | 02 | N | 220035672 | CAPECITABINE |